1974 2021 2021 deu 221 225 5 3 25 article Springer Science and Business Media LLC 1 -- 2021-08-25 -- Somnologie Wiederherstellung der Arbeitsfähigkeit nach Behandlung mit Tasimelteon 1432-9123 10.1007/s11818-021-00314-8 true {"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T13:58:18Z","timestamp":1718373498448},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T00:00:00Z","timestamp":1629849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Somnologie"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s11818-021-00314-8","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T09:03:39Z","timestamp":1629882219000},"page":"221-225","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["M\u00f6gliche Non-24-Schlaf-Wach-Rhythmusst\u00f6rung?"],"prefix":"10.1007","volume":"25","author":[{"given":"Vlad Alexander","family":"S\u0103ndulescu","sequence":"first","affiliation":[]},{"given":"Kneginja","family":"Richter","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,8,25]]},"reference":[{"key":"314_CR1","first-page":"1","volume":"8","author":"MAQ Salva","year":"2017","unstructured":"Salva\u00a0MAQ, Hartley\u00a0S, L\u00e9ger\u00a0D, Dauvilliers\u00a0YA (2017) Non-24-hour sleep-wake rhythm disorder in the totally blind: diagnosis and management. Front Neurol 8:1\u20137","journal-title":"Front Neurol"},{"issue":"5","key":"314_CR2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.5664\/jcsm.5800","volume":"12","author":"EE Flynn-Evans","year":"2016","unstructured":"Flynn-Evans\u00a0EE, Lockley\u00a0SW (2016) A pre-screening questionnaire to predict non-24-hour sleep-wake rhythm disorder (N24HSWD) among the blind. J\u00a0Clin Sleep Med 12(5):703\u2013710","journal-title":"J Clin Sleep Med"},{"issue":"11","key":"314_CR3","first-page":"3763","volume":"82","author":"SW Lockley","year":"1997","unstructured":"Lockley\u00a0SW, Skene\u00a0DJ, Arendt\u00a0J, Tabandeh\u00a0H, Bird\u00a0AC, Defrance\u00a0R (1997) Relationship between melatonin rhythms and visual loss in the blind. J\u00a0Clin Endocrinol Metab 82(11):3763\u20133770","journal-title":"J Clin Endocrinol Metab"},{"key":"314_CR4","volume-title":"International classification of sleep disorders","author":"American Academy of Sleep Medicine","year":"2014","unstructured":"American Academy of Sleep Medicine (2014) International classification of sleep disorders, 3.\u00a0Aufl. American Academy of Sleep Medicine, Darien","edition":"3"},{"issue":"2","key":"314_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s11818-016-0060-x","volume":"20","author":"I Fietze","year":"2016","unstructured":"Fietze\u00a0I, Nissen\u00a0C, Erler\u00a0T, Young\u00a0P (2016) Non-24: eine untersch\u00e4tzte zirkadiane Schlafst\u00f6rung bei Blinden. Somnologie 20(2):119\u2013124","journal-title":"Somnologie"},{"issue":"9662","key":"314_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/S0140-6736(08)61812-7","volume":"373","author":"SM Rajaratnam","year":"2009","unstructured":"Rajaratnam\u00a0SM et al (2009) Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials. Lancet 373(9662):482\u2013491","journal-title":"Lancet"},{"issue":"10005","key":"314_CR7","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/S0140-6736(15)60031-9","volume":"386","author":"SW Lockley","year":"2015","unstructured":"Lockley\u00a0SW et al (2015) Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials. Lancet 386(10005):1754\u20131764","journal-title":"Lancet"},{"issue":"11","key":"314_CR8","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1517\/14740338.2015.1093112","volume":"14","author":"D Leger","year":"2015","unstructured":"Leger\u00a0D, Quera-Salva\u00a0M\u2011A, Vecchierini\u00a0M\u2011F, Ogrizek\u00a0P, Perry\u00a0CA, Dressman\u00a0MA (2015) Safety profile of tasimelteon, a\u00a0melatonin MT1 and MT2 receptor agonist: pooled safety analyses from six clinical studies. Expert Opin Drug Saf 14(11):1673\u20131685","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"314_CR9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1080\/14656566.2019.1603293","volume":"20","author":"S Nishimon","year":"2019","unstructured":"Nishimon\u00a0S, Nishimon\u00a0M, Nishino\u00a0S (2019) Tasimelteon for treating non-24\u2011h sleep-wake rhythm disorder. Expert Opin Pharmacother 20(9):1065\u20131073","journal-title":"Expert Opin Pharmacother"}],"container-title":["Somnologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11818-021-00314-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11818-021-00314-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11818-021-00314-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T23:58:14Z","timestamp":1630713494000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11818-021-00314-8"}},"subtitle":["Wiederherstellung der Arbeitsf\u00e4higkeit nach Behandlung mit Tasimelteon"],"short-title":[],"issued":{"date-parts":[[2021,8,25]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["314"],"URL":"http:\/\/dx.doi.org\/10.1007\/s11818-021-00314-8","relation":{},"ISSN":["1432-9123","1439-054X"],"issn-type":[{"value":"1432-9123","type":"print"},{"value":"1439-054X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,25]]},"assertion":[{"value":"25 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0Richter gibt eine einmalige Referentent\u00e4tigkeit f\u00fcr die Firma Vanda Pharmaceuticals, Berlin, an. V.A.\u00a0S\u0103ndulescu gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Die Einverst\u00e4ndniserkl\u00e4rung des Patienten zur anonymen Publikation des Fallberichts liegt vor. F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}} journal-article https://www.springer.com/tdm crossref PersonAuthorFirstName_1,PersonAuthorLastName_1,PersonAuthorFirstName_2,PersonAuthorLastName_2,PublisherName,TitleMain_1,Language,TitleParent_1,PageNumber,PageFirst,PageLast,Issue,Volume,CompletedYear,IdentifierIssn,Enrichmentlocal_crossrefLicence Begutachtet/Reviewed doi-import false false Vlad Alexander Săndulescu Kneginja Richter Fakultät Sozialwissenschaften Gesundheit